文献速递腹部技术与安全CT

术前增强CT图像分形分析预测无功能胰腺神经内分泌肿瘤分级

Prediction of non-functioning pancreatic neuroendocrine tumor grades with fractal analysis of preoperative contrast-enhanced computed tomography images.
PubMed 文献 · Eur J Radiol · 2021-05-29

回顾性纳入40例无功能胰腺神经内分泌肿瘤患者,于术前增强CT动脉期图像计算肿瘤分形维数最大值FDmax。FDmax与Ki-67指数显著正相关,鉴别G2/3的AUC为0.773,阈值1.036时敏感度62.5%、特异度90.0%。高FD组无病生存期显著更短,多因素分析中高FD是DFS的唯一显著预后因素。

要点

  • FDmax与Ki-67指数显著正相关(p<0.01),提示分形维数可反映肿瘤内异质性。
  • FDmax鉴别G2/3的AUC为0.773,阈值1.036时敏感度62.5%、特异度90.0%。
  • 高FD(≥1.036)组无病生存期显著短于低FD组(p=0.0128)。

核心结论

  • 术前增强CT分形分析得到的肿瘤FDmax可能是预测G2/3无功能胰腺神经内分泌肿瘤及复发的潜在生物标志物。

研究设计与样本

  • 回顾性研究纳入2005年7月至2018年12月在本机构切除的40例无功能胰腺神经内分泌肿瘤患者,排除功能性肿瘤、CT未识别肿瘤及无术前增强CT者,采用插件软件计算分形维数,取最大值FDmax。

关键影像表现/征象

  • 所有CT图像均采集三期,分析动脉期图像。
  • 肿瘤FDmax通过分形分析软件计算,取最大值。

诊断标准与关键数值

  • 按Ki-67指数3%和5%两种阈值分别将患者分为G1与G2/3组。
  • FDmax鉴别G2/3的AUC为0.773,cut-off值1.036时敏感度62.5%、特异度90.0%、PPV 86.2%、NPV 70.6%。
  • 高FD定义为FDmax≥1.036。

临床应用与阅片要点

  • 作者认为FDmax可能作为术前预测G2/3肿瘤及复发的潜在生物标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess intra-tumoral heterogeneity (ITH) via fractal analysis of preoperative contrast-enhanced computed tomography (CT) images to predict pathological grades in non-functioning pancreatic neuroendocrine tumors (NF-PNETs) and verify its impact on patient survival.

METHODS: This retrospective study enrolled 40 patients with NF-PNET resected in our institution during a period from July 2005 to December 2018, except functioning tumors, unidentified tumors in CT, patients without preoperative contrast-enhanced CT. CT images were analyzed using plugin software for calculating fractal dimension (FD), and the maximum value was denoted as "FDmax," and compared with pathological grades and patient survival between G1 and G2/3 group separating according to two different Ki-67 index thresholds (3% and 5%). All CT images were acquired in three-phases and arterial phase images were examined.

RESULTS: Ki-67 index and FDmax showed a direct correlation with significance (p < 0.01). The mean FDmax of the G2/3 tumor group was significantly higher than that of the G1 tumor group (p < 0.01 in both 3% and 5% thresholds). In the ROC analysis, FDmax showed 0.773 of AUC, and cut-off value of 1.036 reported 62.5 % sensitivity, 90.0 % specificity, 86.2 % PPV, and 70.6 % NPV to distinguish G2/3 patients. The high-FD (≥1.036) group showed a significantly shorter disease-free survival (DFS) than the low-FD group (p = 0.0128). In multivariate analysis of prognostic factors, high FD was the only significant factor for DFS (HR, 5.793; 95 % CI: 1.213-27.664; p = 0.028).

CONCLUSIONS: The tumor's FDmax using CE-CT analysis might be a potential biomarker for preoperative prediction of G2/3 tumors, and predicting recurrence.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Nakano A, Hayano K, Tochigi T, et al. Prediction of non-functioning pancreatic neuroendocrine tumor grades with fractal analysis of preoperative contrast-enhanced computed tomography images. Eur J Radiol. 2021. PMID: 34090111. doi:10.1016/j.ejrad.2021.109803

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。